Metastatic HER2-positive Breast Cancer trials recruiting in New York

Fewer than 3 recruiting trials found.

All Metastatic HER2-positive Breast Cancer trials nationally

Cities in New York

Recruiting trials in New York

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
  NCT06435429 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Long Island City, New York